Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy - are these Receptors Valid Therapeutic Targets

By  

Current Drug Targets, Vol. 10, Iss. 1, 2009-01 ,pp. : 42-50

Bentham Science Publishers

Access to resources Recommend Favorite

Advanced Glycation Endproducts and Diabetes. Beyond Vascular Complications

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 11, Iss. 2, 2011-06 ,pp. : 132-140

Bentham Science Publishers

Access to resources Recommend Favorite

Phase I Clinical Studies of the Advanced Glycation End-product (AGE)-Breaker TRC4186: Safety, Tolerability and Pharmacokinetics in Healthy Subjects

By Chandra Kumar P.  

Clinical Drug Investigation, Vol. 29, Iss. 9, 2009-09 ,pp. : 559-575

Adis International

Access to resources Recommend Favorite

Unchanged serum levels of advanced glycation endproducts in patients with liver disease

By Butscheid Moritz   Schäfer Christian   Brenner Stefanie   Alscher Dominik   Mürdter Thomas   Niwa Toshimitsu   Frischmann Matthias   Pischetsrieder Monika   Klotz Ulrich  

Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 375, Iss. 6, 2007-08 ,pp. : 401-406

Springer Publishing Company

Access to resources Recommend Favorite

Advanced Glycation End-products Enhance Calcification in Vascular Smooth Muscle Cells

By Ren X   Shao H   Wei Q   Sun Z   Liu N  

The Journal of International Medical Research, Vol. 37, Iss. 3, 2009-05 ,pp. : 847-854

Field House Publishing

Access to resources Recommend Favorite